Shane Schaffer is the founder of Cingulate Therapeutics. Schaffer is the Co-founder, Chairman, and Chief Executive Officer (CEO) of Cingulate Therapeutics.
Shane J. Schaffer is the Co-founder, Chairman, and Chief Executive Officer (CEO) of Cingulate Therapeutics, a Phase 3 clinical-stage biopharmaceutical company based in Kansas City, Kansas. The company focuses on developing next-generation pharmaceutical products for Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety-associated disorders. Schaffer is also noted as an ADHD advocate alongside his executive role.
Full founder directory · Investor directory · Company funding database · Fundraising library